Home

Disease management

Congress highlights

Early intervention for psychosis: Is it worth the investment?

In a session at WFSBP, chaired by Professor Matcheri Keshavan, Harvard Medical School, Boston, MA,...

Satellite symposium

Maintaining functioning in bipolar disorder: Treat early and prevent relapses

Bipolar disorder (BD) should be considered a neuroprogressive disorder with poor outcomes1 said...

Schizophrenia, Alcohol Dependence

Congress highlights

Decreasing relapse and rehospitalization in first-episode psychosis

More than 50% of people with first-episode psychosis (FEP) have comorbid substance use disorder (...

Congress highlights

A public invitation to view and comment on pre-final APA schizophrenia guideline statements

Many guidelines exist worldwide on how best to manage psychiatric illnesses, but we never see two...

Congress highlights

Adherence in the real world

Non-adherence and lack of engagement commonly mean that patients with serious mental illnesses may...

Congress highlights

Challenges for social psychiatry in a changing world

Modern social risk factors for the development of severe psychiatric disorders, such as migration...

Depression, Schizophrenia

Congress highlights

Lifestyle, the gut, and mental health

Interventions to lower the risk for cardiovascular disease and metabolic syndrome, correction of...

Congress highlights

Social isolation and stigma: Cross-cultural perspectives

Meaningful connection to other people is as essential to health as the air we breathe. So the...

Long-acting injectables – functioning and compliance studies

Two posters presented during SIRS 2019 suggest that use of long-acting injectable (LAI)...

Clinical Use of Body-Swapping! Don’t worry, it’s Virtual Reality!

Digital technologies are unfamiliar to many physicians, yet there is a huge demand for their...

Congress highlights

Psychiatrist and patient partnership encourages trust and effective care

We have so many shared objectives – notably ensuring adequate resources are given to mental...

Treatment can benefit all severities of major depressive disorder

Whether baseline severity of major depressive disorder (MDD) influences the efficacy of...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind MENA Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind South East Asia Continue to Progress in Mind South Africa Continue to Progress in Mind United Kingdom Continue to Progress in Mind Sweden Continue to Progress in Mind Norge Continue to Progress in Mind Denmark Continue to Progress in Mind Finland Continue to Progress in Mind United Kingdom Continue to Progress in Mind United Kingdom Continue to Progress in Mind Japan

You are leaving Progress in Mind

Continue to

Cancel

You are leaving

Progress in Mind Portugal
HCP Access verification required

To gain access, please provide details to verify you are a healthcare professional.

If you are not located in Portugal click here.

Continue to verification page Login with email

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

Accept

Decline